Using the change in party control of the Senate that resulted from Jim Jeffords's 2001 change in party affiliation, we compare competing partisan and partyless legislative theories. We offer a reconceptualization of agenda control that provides a new and promising basis for studying parties and policymaking in the Senate. Also, we present a novel methodology—an “event study”—to test partisan and partyless hypotheses. Our results show that, when Jeffords switched, the stock prices of Republican‐supported energy firms dropped and prices for Democrat‐supported firms rose, supporting the hypothesis that the majority party influences Senate decisions.
Proposes a new theory of Senate agenda setting that reconciles a divide in literature between the conventional wisdom – in which party power is thought to be mostly undermined by Senate procedures and norms – and the apparent partisan bias in Senate decisions noted in recent empirical studies. Chris Den Hartog and Nathan W. Monroe's theory revolves around a 'costly consideration' framework for thinking about agenda setting, where moving proposals forward through the legislative process is seen as requiring scarce resources. To establish that the majority party pays lower agenda consideration costs through various procedural advantages, the book features a number of chapters examining partisan influence at several stages of the legislative process, including committee reports, filibusters and cloture, floor scheduling and floor amendments. Not only do the results support the book's theoretical assumption and key hypotheses, but they shed new light on virtually every major step in the Senate's legislative process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.